# Iqvia Holdings Inc.: financial statements, quarterly

IQV · NYSE · CIK 1478242 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iqv.md) · [Financials](/companies/iqv/financials.md) · [Filings](/companies/iqv/filings.md) · [Insiders](/companies/iqv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iqv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,868 d](/filings/0001628280-26-008322.md) | [3,737](/filings/0001478242-25-000087.md) | [3,814](/filings/0001478242-25-000106.md) | [3,896](/filings/0001628280-25-046794.md) | [3,958 d](/filings/0001628280-26-008322.md) | [3,829](/filings/0001628280-26-030675.md) | [4,017](/filings/0001628280-26-050211.md) | [4,100](/filings/0001628280-26-067646.md) | [4,364 d](/filings/0001628280-26-008322.md) | [4,151](/filings/0001628280-26-030675.md) | [4,368](/filings/0001628280-26-050211.md) | [4,428](/filings/0001628280-26-067646.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | [827](/filings/0001478242-24-000068.md) | [863](/filings/0001478242-24-000097.md) | [915](/filings/0001478242-24-000117.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [556 d](/filings/0001628280-26-008322.md) | [508](/filings/0001478242-25-000087.md) | [509](/filings/0001478242-25-000106.md) | [522](/filings/0001628280-25-046794.md) | [453 d](/filings/0001628280-26-008322.md) | [508](/filings/0001628280-26-030675.md) | [509](/filings/0001628280-26-050211.md) | [514](/filings/0001628280-26-067646.md) | [468 d](/filings/0001628280-26-008322.md) | [502](/filings/0001628280-26-030675.md) | [574](/filings/0001628280-26-050211.md) | [569](/filings/0001628280-26-067646.md) |
| Operating income | $m | [501 d](/filings/0001628280-26-008322.md) | [506](/filings/0001478242-25-000087.md) | [520](/filings/0001478242-25-000106.md) | [550](/filings/0001628280-25-046794.md) | [626 d](/filings/0001628280-26-008322.md) | [496](/filings/0001628280-26-030675.md) | [506](/filings/0001628280-26-050211.md) | [553](/filings/0001628280-26-067646.md) | [627 d](/filings/0001628280-26-008322.md) | [514](/filings/0001628280-26-030675.md) | [506](/filings/0001628280-26-050211.md) | [572](/filings/0001628280-26-067646.md) |
| Interest expense | $m | [181 d](/filings/0001628280-26-008322.md) | [166](/filings/0001478242-25-000087.md) | [163](/filings/0001478242-25-000106.md) | [170](/filings/0001628280-25-046794.md) | [171 d](/filings/0001628280-26-008322.md) | [165](/filings/0001628280-26-030675.md) | [182](/filings/0001628280-26-050211.md) | [189](/filings/0001628280-26-067646.md) | [193 d](/filings/0001628280-26-008322.md) | [192](/filings/0001628280-26-030675.md) | [197](/filings/0001628280-26-050211.md) | [203](/filings/0001628280-26-067646.md) |
| Income tax | $m | [(102) d](/filings/0001628280-26-008322.md) | [49.0](/filings/0001478242-25-000087.md) | [75.0](/filings/0001478242-25-000106.md) | [65.0](/filings/0001628280-25-046794.md) | [112 d](/filings/0001628280-26-008322.md) | [61.0](/filings/0001628280-26-030675.md) | [56.0](/filings/0001628280-26-050211.md) | [76.0](/filings/0001628280-26-067646.md) | [59.0 d](/filings/0001628280-26-008322.md) | [59.0](/filings/0001628280-26-030675.md) | [60.0](/filings/0001628280-26-050211.md) | [76.0](/filings/0001628280-26-067646.md) |
| Net income | $m | [469 d](/filings/0001628280-26-008322.md) | [288](/filings/0001478242-25-000087.md) | [363](/filings/0001478242-25-000106.md) | [285](/filings/0001628280-25-046794.md) | [437 d](/filings/0001628280-26-008322.md) | [249](/filings/0001628280-26-030675.md) | [266](/filings/0001628280-26-050211.md) | [331](/filings/0001628280-26-067646.md) | [514 d](/filings/0001628280-26-008322.md) | [274](/filings/0001628280-26-030675.md) | [256](/filings/0001628280-26-050211.md) | [350](/filings/0001628280-26-067646.md) |
| Diluted EPS | $ per share | not reported | [1.56](/filings/0001478242-25-000087.md) | [1.97](/filings/0001478242-25-000106.md) | [1.55](/filings/0001628280-25-046794.md) | not reported | [1.40](/filings/0001628280-26-030675.md) | [1.54](/filings/0001628280-26-050211.md) | [1.93](/filings/0001628280-26-067646.md) | not reported | [1.61](/filings/0001628280-26-030675.md) | [1.53](/filings/0001628280-26-050211.md) | [2.10](/filings/0001628280-26-067646.md) |
| Basic EPS | $ per share | not reported | [1.58](/filings/0001478242-25-000087.md) | [1.99](/filings/0001478242-25-000106.md) | [1.57](/filings/0001628280-25-046794.md) | not reported | [1.42](/filings/0001628280-26-030675.md) | [1.55](/filings/0001628280-26-050211.md) | [1.94](/filings/0001628280-26-067646.md) | not reported | [1.63](/filings/0001628280-26-030675.md) | [1.54](/filings/0001628280-26-050211.md) | [2.13](/filings/0001628280-26-067646.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0001478242-25-000045.md) | [1.4](/filings/0001478242-24-000068.md) | [1.5](/filings/0001478242-24-000097.md) | [1.6](/filings/0001478242-24-000117.md) | [1.7](/filings/0001628280-26-008322.md) | [1.7](/filings/0001478242-25-000087.md) | [2.0](/filings/0001478242-25-000106.md) | [1.8](/filings/0001628280-25-046794.md) | [2.0](/filings/0001628280-26-067646.md) | [1.9](/filings/0001628280-26-030675.md) | [1.9](/filings/0001628280-26-050211.md) | [2.2](/filings/0001628280-26-067646.md) |
| Current assets | $bn | [5.6](/filings/0001478242-25-000045.md) | [5.7](/filings/0001478242-24-000068.md) | [5.6](/filings/0001478242-24-000097.md) | [5.6](/filings/0001478242-24-000117.md) | [5.8](/filings/0001628280-26-008322.md) | [5.9](/filings/0001478242-25-000087.md) | [6.3](/filings/0001478242-25-000106.md) | [6.0](/filings/0001628280-25-046794.md) | [6.2](/filings/0001628280-26-067646.md) | [6.2](/filings/0001628280-26-030675.md) | [6.2](/filings/0001628280-26-050211.md) | [6.5](/filings/0001628280-26-067646.md) |
| Total assets | $bn | [26.7](/filings/0001478242-25-000045.md) | [26.6](/filings/0001478242-24-000068.md) | [26.4](/filings/0001478242-24-000097.md) | [27.2](/filings/0001478242-24-000117.md) | [26.9](/filings/0001628280-26-008322.md) | [27.3](/filings/0001478242-25-000087.md) | [28.6](/filings/0001478242-25-000106.md) | [28.7](/filings/0001628280-25-046794.md) | [29.9](/filings/0001628280-26-067646.md) | [29.7](/filings/0001628280-26-030675.md) | [29.9](/filings/0001628280-26-050211.md) | [30.5](/filings/0001628280-26-067646.md) |
| Current liabilities | $bn | [6.5](/filings/0001478242-25-000045.md) | [6.4](/filings/0001478242-24-000068.md) | [6.6](/filings/0001478242-24-000097.md) | [7.0](/filings/0001478242-24-000117.md) | [7.0](/filings/0001628280-26-008322.md) | [7.2](/filings/0001478242-25-000087.md) | [7.6](/filings/0001478242-25-000106.md) | [8.5](/filings/0001628280-25-046794.md) | [8.3](/filings/0001628280-26-067646.md) | [8.3](/filings/0001628280-26-030675.md) | [8.8](/filings/0001628280-26-050211.md) | [7.8](/filings/0001628280-26-067646.md) |
| Total liabilities | $bn | [20.6](/filings/0001478242-25-000045.md) | [20.2](/filings/0001478242-24-000068.md) | [19.7](/filings/0001478242-24-000097.md) | [20.2](/filings/0001478242-24-000117.md) | [20.8](/filings/0001628280-26-008322.md) | [21.3](/filings/0001478242-25-000087.md) | [22.8](/filings/0001478242-25-000106.md) | [22.4](/filings/0001628280-25-046794.md) | [23.3](/filings/0001628280-26-067646.md) | [23.3](/filings/0001628280-26-030675.md) | [23.6](/filings/0001628280-26-050211.md) | [23.7](/filings/0001628280-26-067646.md) |
| Long-term debt | $bn | [13.0](/filings/0001478242-25-000045.md) | [12.8](/filings/0001478242-24-000068.md) | [12.1](/filings/0001478242-24-000097.md) | [12.3](/filings/0001478242-24-000117.md) | [12.8](/filings/0001628280-26-008322.md) | [13.1](/filings/0001478242-25-000087.md) | [14.2](/filings/0001478242-25-000106.md) | [12.8](/filings/0001628280-25-046794.md) | [13.9](/filings/0001628280-26-067646.md) | [14.0](/filings/0001628280-26-030675.md) | [13.7](/filings/0001628280-26-050211.md) | [14.8](/filings/0001628280-26-067646.md) |
| Current portion of debt | $bn | [0.7](/filings/0001478242-25-000045.md) | [0.7](/filings/0001478242-24-000068.md) | [1.2](/filings/0001478242-24-000097.md) | [1.2](/filings/0001478242-24-000117.md) | [1.1](/filings/0001628280-26-008322.md) | [1.2](/filings/0001478242-25-000087.md) | [1.3](/filings/0001478242-25-000106.md) | [2.2](/filings/0001628280-25-046794.md) | [1.8](/filings/0001628280-26-067646.md) | [1.8](/filings/0001628280-26-030675.md) | [2.3](/filings/0001628280-26-050211.md) | [1.2](/filings/0001628280-26-067646.md) |
| Shareholders' equity | $bn | [6.1](/filings/0001478242-24-000117.md) | [6.3](/filings/0001478242-24-000068.md) | [6.7](/filings/0001478242-24-000097.md) | [7.0](/filings/0001478242-24-000117.md) | [6.1](/filings/0001628280-26-008322.md) | [6.0](/filings/0001478242-25-000087.md) | [5.8](/filings/0001478242-25-000106.md) | [6.2](/filings/0001628280-25-046794.md) | [6.5](/filings/0001628280-26-067646.md) | [6.2](/filings/0001628280-26-030675.md) | [6.2](/filings/0001628280-26-050211.md) | [6.7](/filings/0001628280-26-067646.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [747 d](/filings/0001628280-26-008322.md) | [522](/filings/0001478242-25-000087.md) | [588 d](/filings/0001478242-25-000106.md) | [721 d](/filings/0001628280-25-046794.md) | [885 d](/filings/0001628280-26-008322.md) | [568](/filings/0001628280-26-030675.md) | [443 d](/filings/0001628280-26-050211.md) | [908 d](/filings/0001628280-26-067646.md) | [735 d](/filings/0001628280-26-008322.md) | [618](/filings/0001628280-26-030675.md) | [558 d](/filings/0001628280-26-050211.md) | [825 d](/filings/0001628280-26-067646.md) |
| Capital expenditure | $m | [179 d](/filings/0001628280-26-008322.md) | [145](/filings/0001478242-25-000087.md) | [143 d](/filings/0001478242-25-000106.md) | [150 d](/filings/0001628280-25-046794.md) | [164 d](/filings/0001628280-26-008322.md) | [142](/filings/0001628280-26-030675.md) | [151 d](/filings/0001628280-26-050211.md) | [136 d](/filings/0001628280-26-067646.md) | [174 d](/filings/0001628280-26-008322.md) | [127](/filings/0001628280-26-030675.md) | [198 d](/filings/0001628280-26-050211.md) | [158 d](/filings/0001628280-26-067646.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [229 d](/filings/0001628280-26-008322.md) | [0.0](/filings/0001478242-25-000087.md) | [0.0 d](/filings/0001478242-25-000106.md) | [200 d](/filings/0001628280-25-046794.md) | [1,150 d](/filings/0001628280-26-008322.md) | [375](/filings/0001628280-26-030675.md) | [657 d](/filings/0001628280-26-050211.md) | [0.0 d](/filings/0001628280-26-067646.md) | [212 d](/filings/0001628280-26-008322.md) | [552](/filings/0001628280-26-030675.md) | [398 d](/filings/0001628280-26-050211.md) | [0.0 d](/filings/0001628280-26-067646.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [189](/filings/0001478242-24-000068.md) | [187](/filings/0001478242-24-000097.md) | [186](/filings/0001478242-24-000117.md) | [184](/filings/0001478242-25-000087.md) | [184](/filings/0001478242-25-000106.md) | [184](/filings/0001628280-25-046794.md) | [177](/filings/0001628280-26-030675.md) | [173](/filings/0001628280-26-050211.md) | [172](/filings/0001628280-26-067646.md) | [170](/filings/0001628280-26-030675.md) | [167](/filings/0001628280-26-050211.md) | [167](/filings/0001628280-26-067646.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 164,800,000 at 2026-10-20, from the cover of the [10-Q filed 2026-10-27](/filings/0001628280-26-067646.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 22:09 ET. No prices; not investment advice.